Drugs.com

Drugs.com

Drugs.com stands as the biggest and most popular independent website for medicine information online. Our goal is to become the most reliable source for drug and health-related information on the Internet. We strive to reach this goal by offering unbiased, thorough, and current information in a straightforward and easy-to-understand way for both consumers and healthcare providers.

International
English
Online/Digital

Outlet metrics

Domain Authority
84
Ranking

Global

#2447

United States

#654

Health/Pharmacy

#3

Traffic sources
Monthly visitors

Articles

  • 1 month ago | drugs.com | Leigh Ann Anderson

    Recently Approved Vanrafia Vanrafia (atrasentan) is an endothelin A receptor antagonist used for... Qfitlia Qfitlia (fitusiran) is an antithrombin-directed small interfering ribonucleic... Vykat XR Vykat XR (diazoxide choline) is an extended-release formulation of the...

  • May 28, 2024 | drugs.com | Leigh Ann Anderson

    Can Gemtesa cause dementia? Cognitive decline, which may include dementia, memory loss and confusion, is not a known side effect for Gemtesa (vibegron) or the beta-3 agonist class as a whole. In addition, a study found the use of anticholinergic medications among patients with overactive bladder (OAB) was associated with an increased risk of new-onset dementia compared to beta-3 agonist users.

  • Jan 16, 2024 | drugs.com | Leigh Ann Anderson

    There are no specific foods to avoid, but if you are being treated for type 2 diabetes you should avoid regular consumption of foods high in fat, sugar and calories. Rybelsus works best if you combine it with a healthy diet and exercise plan as recommended by your healthcare provider. Although you don't have to avoid specific foods with Rybelsus, but you must take this medicine on an empty stomach when you first wake up with a sip of plain water (4 ounces or less).

  • Aug 24, 2023 | drugs.com | Leigh Ann Anderson

    Ingrezza (valbenazine) capsules and Ingrezza Sprinkle capsules are approved for the treatment of adults with tardive dyskinesia and for adults with chorea associated with Huntington's disease (HD), two types of involuntary movement disorders. Ingrezza is a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor. Tardive dyskinesia (TD) is characterized by abnormal and repetitive movements of the trunk, extremities or face.

  • Aug 23, 2023 | drugs.com | Leigh Ann Anderson

    Ingrezza (valbenazine) and Ingrezza Sprinkle capsules, from Neurocrine Biosciences, are both available through a special pharmacy network and special local pharmacies in the U.S. These may include: AllianceRx Walgreens Pharmacy* (1-877-627-6337) Amber Specialty Pharmacy (1-888-370-1724) CVS Specialty (1-866-215-9855) Genoa Healthcare Pharmacies (1-855-657-6554, option 2) Orsini Specialty Pharmacy (1-800-279-1676) PantherRx Rare (1-844-221-3777) Select local and community pharmacies * If a...

Drugs.com journalists

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations